Fig. 1.
Assessment of endurance according to the 6-min walking test (6-MWT) at baseline and after 8 months of elosulfase alfa therapy in the Morquio A Early Access Program (MOR-EAP).
A 0 score was given to patients who did not walk.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.